AlphaFold predicted structure
MRM2 · Q9UI43

Mean pLDDT
88.3/ 100
Confident
246 residues
Confidence breakdown
- Very high(≥ 90)78%
- Confident(70–90)9%
- Low(50–70)1%
- Very low(< 50)12%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
mitochondrial rRNA methyltransferase 2
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Likely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalmitochondrial DNA depletion syndrome 17
mitochondrial DNA depletion syndrome
neuroblastoma
Abnormality of the skeletal system
retinitis pigmentosa
Progressive cone dystrophy
Cone rod dystrophy
atrial fibrillation
Leber congenital amaurosis
Familial exudative vitreoretinopathy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
rRNA methyltransferase 2, mitochondrial
S-adenosyl-L-methionine-dependent 2'-O-ribose methyltransferase that catalyzes the formation of 2'-O-methyluridine at position 1369 (Um1369) in the 16S mitochondrial large subunit ribosomal RNA (mtLSU rRNA), a universally conserved modification in the peptidyl transferase domain of the mtLSU rRNA (PubMed:25009282, PubMed:25074936, PubMed:35177605). This activity may require prior 2'-O-methylguanosine modification at position 1370 (Gm1370) by MRM3 (PubMed:35177605). Essential for late-stage assembly of mtLSU required for efficient translation of mitochondrial DNA encoded proteins; methyltransferase activity is not required for this function (PubMed:35177605). Essential for mitochondrial respiratory function (PubMed:35177605)
MRM2 · Q9UI43

Mean pLDDT
88.3/ 100
Confident
246 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0